What Are Reimports?

We, ACA Müller Pharma, import pharmaceuticals and medical products from other EU member states and distribute them to pharmacies and wholesale traders as well as medical stores, clinics, and care homes in Germany and across the globe. This allows us to fulfill an important role in the health system.

Your Benefits

Prices for drugs and medical products vary a lot across the EU. We utilize this price difference, which is how we are able to supply our customers with the same branded products at a discounted price. And it’s not just our customers, who benefit from these savings. The entire healthcare system – insurers, patients, and doctors - benefits from this practice.

Patients

Patienten

Reimports enable patients to buy branded pharmaceuticals at a discounted price. The quality is ensured every step of the way. Our products are continuously controlled by both internal and external experts. Patients can rest assured that they are really saving on the cost and not the quality with ACA Müller products.

Pharmacies

Apotheken

ACA Müller helps pharmacies meet their quotas on reimported medical supplies knowing that their customers are receiving the best quality for a smaller price. In addition to that, ACA Müller carries strong and attractive brands in its portfolio that help pharmacies expand their customer pool and business.

Society

Gesellschaft

ACA Müller’s reimports are good for the entire health care system. Doctor’s prescription budgets are relieved as they can prescribe the same drugs for less. Insurers also benefit from the smaller price that ACA Müller is able to offer. Health insurer contributions are stabilized and state requirements are met.

FAQ – Frequently Asked Questions

Import-pharmaceuticals or Euro-pharmaceuticals can either be “parallel imports” or “reimports“. “Parallel imports” means that pharmaceuticals manufactured by the original brand in other EU countries are purchased in those countries and “imported“ to Germany. “Reimports” are drugs produced by the original brand in Germany which had been exported to other EU countries. We purchase them there from a wholesaler and “reimport” them to Germany.

Yes, we only deal with original pharmaceuticals from Europe that are identical to the German originals in their therapeutic effect. The EMEA (European Agency for the Evaluation of Medicinal Products) ensures that only identical pharmaceuticals are traded.

No. Reimported and parallel imported drugs are products from the original manufacturer. The EMEA (European Agency for the Evaluation of Medicinal Products) ensures that only identical pharmaceuticals are traded. We are considered a manufacturer according to German law and are thus subject to the same safety regulations as a pharmaceutical manufacturer in the traditional sense. Our products are examined by experts, thus meeting all legal requirements. We value long term trading relationships with our suppliers which minimizes the risk of counterfeited products. The mutual sense of trust in combination with the required quality controls are the best protection against fraud.

Yes, as long as they are aware that the products are made by the original manufacturer and that they posses the same therapeutic value as the original products. For products paid for by the consumers themselves (e.g. contraceptives), patients frequently ask for cheaper alternatives themselves.

Yes, many branded pharmaceuticals are much cheaper in other countries of the EU. German prices for pharmaceuticals are some of the highest in all of Europe. We buy original products by the same brand for a lower price in other countries of the EU and pass savings of up to 30% on to the customers, patients, and insurers.

Yes, just as any other German drug our products are carried by pharmaceutical wholesalers. In addition to that we also offer direct sales.

Many pharmacies have realized that cooperation with us means a steady second source of income. Additionally, they are able to increase customer satisfaction by being able to offer better prices. According to a decree by statutory health insurers, 7,5% of all pharmaceuticals sold in pharmacies must be imports.